Cargando…

Chicken bile powder protects against α-naphthylisothiocyanate-induced cholestatic liver injury in mice

This study explored the effects of chicken bile powder (CBP), a 2000-year-old Chinese medicine, on α-naphthyl isothiocyanate (ANIT)-induced intrahepatic cholestasis in mice. CBP treatment for 14 days significantly ameliorated ANIT-induced changes in serum alanine aminotransferase, aspartate aminotra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yi-Fei, Wu, Jia-Sheng, Li, Yuan-Yuan, Dai, Yan, Zheng, Min, Zeng, Jia-Kai, Wang, Guo-Feng, Wang, Tian-Ming, Li, Wen-Kai, Zhang, Xue-Yan, Gu, Ming, Huang, Cheng, Yang, Li, Wang, Zheng-Tao, Ma, Yue-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722551/ https://www.ncbi.nlm.nih.gov/pubmed/29228599 http://dx.doi.org/10.18632/oncotarget.21385

Ejemplares similares

Huangqi Decoction Alleviates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis by Reversing Disordered Bile Acid and Glutathione Homeostasis in Mice
por: Wu, Jia-Sheng, et al.
Publicado: (2017)

Large dose means significant effect – dose and effect relationship of Chi-Dan-Tui-Huang decoction on alpha-naphthylisothiocyanate-induced cholestatic hepatitis in rats
por: Zhao, Yanling, et al.
Publicado: (2015)

Quercetin 7-rhamnoside protects against alpha-naphthylisothiocyanate (ANIT)-induced in cholestatic hepatitis rats by improving biliary excretion and inhibiting inflammatory responses
por: Jin, Hong-Liu, et al.
Publicado: (2023)

Herbal medicine Yinchenhaotang protects against α-naphthylisothiocyanate-induced cholestasis in rats
por: Yan, Jingyu, et al.
Publicado: (2017)

Arbutin Alleviates the Liver Injury of α-Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation
por: Wu, Peijie, et al.
Publicado: (2021)

A Network Pharmacology Study of the Molecular Mechanisms of Hypericum japonicum in the Treatment of Cholestatic Hepatitis with Validation in an Alpha-Naphthylisothiocyanate (ANIT) Hepatotoxicity Rat Model
por: Feng, Sen Ling, et al.
Publicado: (2021)

Glycyrrhetinic Acid Protects α-Naphthylisothiocyanate- Induced Cholestasis Through Regulating Transporters, Inflammation and Apoptosis
por: Yan, Miao, et al.
Publicado: (2021)

Danning tablets attenuates α-naphthylisothiocyanate-induced cholestasis by modulating the expression of transporters and metabolic enzymes
por: Ding, Lili, et al.
Publicado: (2014)

Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease
por: Shi, Qingmiao, et al.
Publicado: (2023)

MRGPRX4 is a bile acid receptor for human cholestatic itch
por: Yu, Huasheng, et al.
Publicado: (2019)

Protective Effect of Brazilian Propolis against Liver Damage with Cholestasis in Rats Treated with α-Naphthylisothiocyanate
por: Nakamura, Tadashi, et al.
Publicado: (2013)

Bile acid-mediated signaling in cholestatic liver diseases
por: Zeng, Jing, et al.
Publicado: (2023)

Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats
por: Tian, Bin, et al.
Publicado: (2016)

Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
por: Wei, Shizhang, et al.
Publicado: (2020)

Non-invasive biomarkers for identification of vanishing bile duct syndrome among children with acute cholestatic hepatitis
por: Wang, Neng-Li, et al.
Publicado: (2023)

PPARα activation protects against cholestatic liver injury
por: Zhao, Qi, et al.
Publicado: (2017)

Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease
por: Tyc, Olaf, et al.
Publicado: (2020)

The role of bile acids in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2021)

Metabolomic Analysis Reveals the Therapeutic Effects of MBT1805, a Novel Pan-Peroxisome Proliferator-Activated Receptor Agonist, on α-Naphthylisothiocyanate-Induced Cholestasis in Mice
por: Wang, Chang, et al.
Publicado: (2021)

Methimazole-induced cholestatic hepatitis: two cases report and literature review
por: Zou, Hai, et al.
Publicado: (2015)

Bile Nephropathy in Flucloxacillin-Induced Cholestatic Liver Dysfunction
por: Alnasrallah, Basil, et al.
Publicado: (2016)

Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis
por: Gui, Wenfang, et al.
Publicado: (2023)

Kinsenoside Alleviates 17α-Ethinylestradiol-Induced Cholestatic Liver Injury in Rats by Inhibiting Inflammatory Responses and Regulating FXR-Mediated Bile Acid Homeostasis
por: Ming, Jiaxiong, et al.
Publicado: (2021)

Shenqi Fuzheng Injection impairs bile duct ligation-induced cholestatic liver injury in vivo
por: Cao, Fei, et al.
Publicado: (2019)

Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection
por: Yan, Li-Ting, et al.
Publicado: (2020)

Bile acid patterns in commercially available oxgall powders used for the evaluation of the bile tolerance ability of potential probiotics
por: Hu, Peng-Li, et al.
Publicado: (2018)

A novel murine model of reversible bile duct obstruction demonstrates rapid improvement of cholestatic liver injury
por: Taylor, Sarah A., et al.
Publicado: (2020)

Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice
por: Abshagen, Kerstin, et al.
Publicado: (2015)

Positive Effects of Ger-Gen-Chyn-Lian-Tang on Cholestatic Liver Fibrosis in Bile Duct Ligation-Challenged Mice
por: Chang, Zi-Yu, et al.
Publicado: (2019)

Early versus delayed laparoscopic common bile duct exploration for common bile duct stone-related nonsevere acute cholangitis
por: Zhu, Bin, et al.
Publicado: (2015)

Alterations of Gut Microbiota in Cholestatic Infants and Their Correlation With Hepatic Function
por: Guo, Cheng, et al.
Publicado: (2018)

Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress
por: Muchova, Lucie, et al.
Publicado: (2011)

Outcomes of laparoscopic bile duct exploration for choledocholithiasis with small common bile duct
por: Huang, Xiao-Xiao, et al.
Publicado: (2021)

The protective effect of allopurinol on cholestatic liver injury induced by bile duct ligation.
por: Mun, K. C., et al.
Publicado: (1996)

Highlight report: Protection of cholestatic livers by shunting of bile from canaliculi to sinusoids
por: Abbass, Tahany, et al.
Publicado: (2018)

Studies on the mechanisms of bile acid initiated hepatic inflammation in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2017)

8β-Acetoxy-14α-benzoyloxy-N-methyl-13β,15α-dihydroxy-1α,6α,16β-trimethoxy-4β-(methoxymethyl)aconitane: hypaconitine isolated from ‘fuzi’
por: Zheng, Ling-Li, et al.
Publicado: (2010)

Corrigendum: Alterations of Gut Microbiota in Cholestatic Infants and Their Correlation With Hepatic Function
por: Guo, Cheng, et al.
Publicado: (2020)

Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity
por: Verhaag, Esther M., et al.
Publicado: (2016)

Effect of green tea and mulberry leaf powders on the gut microbiota of chicken
por: Chen, Yuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f512mp4fl2jpebldhq5nnegc4h